244 AFNT-111, a safe and effective TCR-engineered T cell therapy targeting the oncogenic driver KRAS G12V mutation

Hubert Lam; Xingyue He; Cheryl Black; Michele Hoffmann; Joshua Francis; James Parsons; Christian Roy; Jinsheng Liang; Hongjing Qu; Martin Campbell; Tomasz Sewastianik; Jessica Webb; Aude Chapuis; Thomas Schmitt; Philip Greenberg; Damien Hallet; Markus Vallaster; Piotr Pierog; Gary Shapiro; Loic Vincent

doi:10.1136/jitc-2022-SITC2022.0244

Article info

PDF

Regular and Young Investigator Award Abstracts

Cell Therapies

244 AFNT-111, a safe and effective TCR-engineered T cell therapy targeting the oncogenic driver KRAS G12V mutation

Free

Authors

Hubert Lam Affini-T Therapeutics, Watertown, MA, USA PubMed articles Google scholar articles
Xingyue He Affini-T Therapeutics, Watertown, MA, USA PubMed articles Google scholar articles
Cheryl Black Affini-T Therapeutics, Watertown, MA, USA PubMed articles Google scholar articles
Michele Hoffmann Affini-T Therapeutics, Watertown, MA, USA PubMed articles Google scholar articles
Joshua Francis Affini-T Therapeutics, Watertown, MA, USA PubMed articles Google scholar articles
James Parsons Affini-T Therapeutics, Watertown, MA, USA PubMed articles Google scholar articles
Christian Roy Affini-T Therapeutics, Watertown, MA, USA PubMed articles Google scholar articles
Jinsheng Liang Affini-T Therapeutics, Watertown, MA, USA PubMed articles Google scholar articles
Hongjing Qu Affini-T Therapeutics, Watertown, MA, USA PubMed articles Google scholar articles
Martin Campbell Affini-T Therapeutics, Watertown, MA, USA PubMed articles Google scholar articles
Tomasz Sewastianik Affini-T Therapeutics, Watertown, MA, USA PubMed articles Google scholar articles
Jessica Webb Fred Hutchinson Cancer Research Center, Seattle, WA, USA PubMed articles Google scholar articles
Aude Chapuis Fred Hutchinson Cancer Research Center, Seattle, WA, USA PubMed articles Google scholar articles
Thomas Schmitt Fred Hutchinson Cancer Research Center, Seattle, WA, USA PubMed articles Google scholar articles
Philip Greenberg Fred Hutchinson Cancer Research Center, Seattle, WA, USA PubMed articles Google scholar articles
Damien Hallet Affini-T Therapeutics, Watertown, MA, USA PubMed articles Google scholar articles
Markus Vallaster Affini-T Therapeutics, Watertown, MA, USA PubMed articles Google scholar articles
Piotr Pierog Affini-T Therapeutics, Watertown, MA, USA PubMed articles Google scholar articles
Gary Shapiro Affini-T Therapeutics, Watertown, MA, USA PubMed articles Google scholar articles
Loic Vincent Affini-T Therapeutics, Watertown, MA, USA PubMed articles Google scholar articles

Citation

Lam H, He X, Black C, et al

244 AFNT-111, a safe and effective TCR-engineered T cell therapy targeting the oncogenic driver KRAS G12V mutation

Journal for ImmunoTherapy of Cancer 2022;10:doi: 10.1136/jitc-2022-SITC2022.0244

Publication history

First published November 7, 2022.

Online issue publication

April 26, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password